期刊文献+

山稔子挥发油化学组成研究 被引量:20

Analysis of Volatile Components from the Fructus rhodomyrti
下载PDF
导出
摘要 采用乙醚超声波萃取法提取广东稔子中的挥发油。以毛细管气相色谱-质谱联用技术对其进行分离、鉴定,鉴定了33种化学成分。并用面积归一法确定其相对含量.研究结果表明稔子挥发油中含有3-甲基-α-蒎烯,反-石竹烯,香树烯(香橙烯),荜澄茄烯(杜松烯)等多种具有药理活性的成分。因此,广东稔子是一种具有较好前景的天然药用资源。 The volatile oil was extracted from the Fructus rhodomyrti using ethyl ether by supersonic. The chemical constituents in the essential oils were analyzed by GC/MS. The relative contents of the constituents were determined by peak area nomalization method. Thirty-three identified compounds mainly included methyl-apopinene, trans-caryophyllene, ( + ) -aromadendrene, δ-cadinene, which had high pharnmacological effect. Fructus rhodomyrti is a kind of natural drug resource, which holds enormous potential.
出处 《中山大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第6期135-137,共3页 Acta Scientiarum Naturalium Universitatis Sunyatseni
基金 广东省自然科学基金资助项目(63116)
关键词 山稔子 挥发油 GC/MS Fructus rhodomyrti volatile oils GC/MS
  • 相关文献

参考文献6

二级参考文献27

  • 1刘力,张若蕙,刘洪谔,竺叶青,周骋,叶苏芳.蜡梅科7树种的叶精油成分及其分类意义[J].植物分类学报,1995,33(2):171-174. 被引量:37
  • 2李萍,何明,涂长春,王勇军,黄起王,胡炜.山腊梅感冒茶抑菌抗炎解热作用的实验研究[J].中国中医药科技,1996,3(1):19-20. 被引量:31
  • 3张晓彦,李成忠.东菱精纯克栓酶治疗突发性耳聋的疗效观察[J].临床耳鼻咽喉科杂志,1996,10(1):59-60. 被引量:29
  • 4中华医学会耳鼻咽喉科学分会 中华耳鼻咽喉科杂志编辑委员会.慢性鼻窦炎鼻息肉临床分型分期及内窥镜鼻窦手术疗效评定标准[J].中华耳鼻咽喉科杂志,1998,33(3):134-134.
  • 5陈凯 李铎贤.鼻咽镜下扩张再通咽鼓管注药治疗分泌性中耳炎[J].临床耳鼻咽科杂志,1998,12:160-160.
  • 6[1]Kaschke O,Behrbonm H,Endoscopic Surgery of Sinusitis.The importance of poseoperative treatment[J].Therapy Week,1994:7408~7412.
  • 7[2]Gelomyrtol forte product information[J].Therapy Week,1994:5.
  • 8Straehler-Pohl HJ, Burmeister G. Use of Gelomyrtol forte in sinusitides A course study[J]. ZFA (Stuttgart). 1978, Apr 54:611-615.
  • 9Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind,randomized multicenter study compared with placebo[J]. Laryngorhinootologie. 1997, 76:23-27.
  • 10Matthys H, De Mey C, Carls C, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. Cefuroxime and ambroxol[ J ]. Arzneimittelforschung,2000, 50:700-711.

共引文献119

同被引文献270

引证文献20

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部